Increased oxidative stress in patients with essential thrombocythemia

被引:0
作者
Durmus, A. [1 ]
Mentese, A. [2 ]
Yilmaz, M. [3 ]
Sumer, A. [2 ]
Akalin, I. [1 ]
Topal, C. [4 ]
Alver, A. [2 ]
机构
[1] Kanuni Training & Res Hosp, Dept Hematol, Trabzon, Turkey
[2] Karadeniz Tech Univ, Fac Med, Dept Biochem, Trabzon, Turkey
[3] Karadeniz Tech Univ, Fac Med, Dept Hematol, Trabzon, Turkey
[4] Kanuni Training & Res Hosp, Dept Nephrol, Trabzon, Turkey
关键词
Essential thrombocythemia; Vascular event; Oxidative stress; Antioxidant status; TOTAL ANTIOXIDANT CAPACITY; RISK-FACTORS; VASCULAR COMPLICATIONS; PROGNOSTIC-FACTORS; ENZYME-ACTIVITIES; MYELOFIBROSIS; THROMBOSIS; DISEASE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Essential thrombocythemia (ET) is a clonal disease in which thrombotic and hemorrhagic complications are common. Our aim in this study was to investigate whether oxidative stress in ET patients increased compared to healthy volunteers and to investigate whether there is a relationship between vascular events and oxidative status parameters in ET patients. PATIENTS AND METHODS: We determined the serum levels of oxidative status parameters, such as total oxidative status (TOS), total antioxidant status (TAS), oxidative stress index (OSI) and malondialdehyde (MDA) in ET patients. Forty-three ET patients (20 males, 23 females) and 20 healthy volunteers were enrolled. Oxidative status parameters of the patients were compared with those of the controls at time of diagnosis and at 6th-month follow-up. Additionally, oxidative status parameters of patients with ET with a history of vascular event were compared with patients without a vascular event history during diagnosis. RESULTS: Rises in TOS, OSI, and MDA were statistically significant in the patients group; however, the TAS value was significantly lower compared to the control group. Furthermore, TOS was significantly higher in patients with history of vascular event compared to the patients without such a history. Following therapy, OSI and MDA values were significantly reduced in the patient group compared to the pre-treatment values. CONCLUSIONS: Our findings reveal that although oxidative stress parameters were increased, compensative total antioxidant status was significantly reduced in ET patients. Furthermore, TOS values were significantly high in patients with a history of vascular event.
引用
收藏
页码:2860 / 2866
页数:7
相关论文
共 35 条
  • [1] Essential thrombocythemia in young individuals:: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients
    Alvarez-Larran, A.
    Cervantes, F.
    Bellosillo, B.
    Giralt, M.
    Julia, A.
    Hernandez-Boluda, J. C.
    Bosch, A.
    Hernandez-Nieto, L.
    Clapes, V.
    Burgaleta, C.
    Salvador, C.
    Arellano-Rodrigo, E.
    Colomer, D.
    Besses, C.
    [J]. LEUKEMIA, 2007, 21 (06) : 1218 - 1223
  • [2] [Anonymous], 1985, Oxidative stress and vascular disease, DOI DOI 10.1016/B978-0-12-642760-8.50005-3
  • [3] Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers
    Aycicek, A
    Erel, O
    Kocyigit, A
    [J]. PEDIATRICS INTERNATIONAL, 2005, 47 (06) : 635 - 639
  • [4] Major vascular complications in essential thrombocythemia:: a study of the predictive factors in a series of 148 patients
    Besses, C
    Cervantes, F
    Pereira, A
    Florensa, L
    Solé, F
    Hernández-Boluda, C
    Woessner, S
    Sans-Sabrafen, J
    Rozman, C
    Montserrat, E
    [J]. LEUKEMIA, 1999, 13 (02) : 150 - 154
  • [5] Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy
    Campbell, Peter J.
    Bareford, David
    Erber, Wendy N.
    Wilkins, Bridget S.
    Wright, Penny
    Buck, Georgina
    Wheatley, Keith
    Harrison, Claire N.
    Green, Anthony R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) : 2991 - 2999
  • [6] Cao GH, 1998, CLIN CHEM, V44, P1309
  • [7] Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
    Carobbio, Alessandra
    Finazzi, Guido
    Antonioli, Elisabetta
    Guglielmelli, Paola
    Vannucchi, Alessandro M.
    Delaini, Federica
    Guerini, Vittoria
    Ruggeri, Marco
    Rodeghiero, Francesco
    Rambaldi, Alessandro
    Barbui, Tiziano
    [J]. BLOOD, 2008, 112 (08) : 3135 - 3137
  • [8] HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS
    CORTELAZZO, S
    FINAZZI, G
    RUGGERI, M
    VESTRI, O
    GALLI, M
    RODEGHIERO, F
    BARBUI, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) : 1132 - 1136
  • [9] INCIDENCE AND RISK-FACTORS FOR THROMBOTIC COMPLICATIONS IN A HISTORICAL COHORT OF 100 PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    CORTELAZZO, S
    VIERO, P
    FINAZZI, G
    DEMILIO, A
    RODEGHIERO, F
    BARBUI, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 556 - 562
  • [10] Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schonlein purpura
    Ece, Aydin
    Kelekci, Selvi
    Kocamaz, Halil
    Hekimoglu, Askin
    Balik, Hasan
    Yolbas, Ilyas
    Erel, Ozcan
    [J]. CLINICAL RHEUMATOLOGY, 2008, 27 (02) : 163 - 169